Oura vs Whoop: Accuracy, Price and Which to Buy

Both devices have now been measured against the same ECG reference in the same study, which is the comparison this question needs. Thirteen healthy adults, six of them female, wore an ECG reference and five wearables simultaneously across 536 nights. Interdevice accuracy varied significantly.

For nocturnal HRV, Oura Generation 4 agreed most closely with the ECG, at a Lin's concordance of 0.99 and mean absolute percentage error of 5.96 plus or minus 5.12 percent, followed by Oura Generation 3 at 0.97 and 7.15 plus or minus 5.48 percent. Whoop 4.0 was moderate at 0.94 and 8.17 plus or minus 10.49 percent. Garmin Fenix 6 and Polar Grit X Pro agreed poorly, at 0.87 and 0.82. The same ordering held for nocturnal resting heart rate, where Whoop was moderate at 0.91 with 3.00 plus or minus 2.15 percent error and Garmin was excluded from that analysis for methodological inconsistencies.

The spread matters as much as the average here. Whoop's HRV error carries a standard deviation of 10.49 percent against a mean of 8.17, larger than the mean itself, where Oura Generation 4's is 5.12 against 5.96. A reader comparing one night to the next is reading a number that moves around more on Whoop than on Oura, independently of which device is closer on average. Oura's nightly RMSSD also has four earlier ECG comparisons behind it, one with an Oura-affiliated author and one whose authors had data access from Oura, converging on strong agreement for the nightly average despite more error in short windows and in wearers over 45.

Polysomnography studies exist for both devices' underlying sleep-wake and stage-detection algorithms, and they land on the same shape of result: strong sleep-versus-wake detection with a real gap in stage classification. Multiple studies of Oura found excellent sleep-wake agreement (0.88 to 0.89 epoch accuracy) alongside tens of minutes of systematic bias in light and deep sleep. A 2025 six-device study that included a Whoop 4.0 found over 90 percent sensitivity for detecting sleep across every device tested, but wake specificity of only 29 to 52 percent and fair-to-moderate stage agreement (Cohen's kappa 0.21 to 0.53); the study named three other brands' devices specifically as its higher-kappa performers, which places Whoop outside that top tier without giving its own figure.

Two studies did test both devices on the same people. In one sleep-lab night with 53 adults, an Oura Ring Gen 2 and a WHOOP 3.0 classified sleep stages about equally well, 61 and 60 percent agreement with polysomnography, in a study from a lab that receives funding and equipment from WHOOP. Over five nights of home polysomnography, the Oura Ring 3 agreed 72.5 percent of the time and the Whoop 4 68.68 percent, in a preprint not yet peer reviewed. Neither study is large enough to declare a winner.

Dedicated searches for independent validation of either composite stress score, Oura's Daytime Stress or Whoop's Stress Monitor, against a reference measure of psychological stress returned nothing for either brand. What exists is separate evidence for the heart-rate and HRV signals each score is built from, not for what either brand's specific combination of them actually tracks.

Dedicated searches turned up no independent validation of either device's blood oxygen sensing against reference oximetry. The general pulse-oximetry literature documents real accuracy problems this feature would inherit regardless of brand, including skin-pigmentation bias and reduced accuracy from motion artifact, but whether either implementation handles those conditions well is unknown rather than good or bad for both.